NCT06487741 Efficacy of a Home-based Stretching Program on Fibromyalgia Symptoms: a Randomised Controlled Trial
| NCT ID | NCT06487741 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College of Northern Denmark |
| Condition | Fibromyalgia |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2024-10-31 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomised controlled trial will examine the clinical efficacy of a six-week, novel, home-based stretching programme compared to usual care on the effect of symptoms experienced by patients with fibromyalgia.
Eligibility Criteria
Inclusion Criteria: * individuals diagnosed with fibromyalgia in accordance with the ACR 2016 diagnostic criteria. * individuals diagnosed with chronic non-malignant pain or individuals diagnosed with chronic widespread pain (including fibromyalgia syndrome) are also included when they meet the ACR 2016 diagnostic criteria. Exclusion Criteria: * Non-controlled systemic disorders (such as hypertension, diabetes and coronary insufficiency), * neurological conditions that impair alertness or comprehension, musculoskeletal conditions that could compromise assessments (such as nerve root compression or knee joint inflammation), * relevant joint disorders (such as severe arthritis, arthroplasty of the hip or knee, and rheumatoid arthritis), * recent changes in therapy for fibromyalgia (i.e., within four weeks of baseline).
Contact & Investigator
Lise Eckardt, Pt. Msc
STUDY DIRECTOR
Department of Physiotherapy, University College of Northern Denmark
Frequently Asked Questions
Who can join the NCT06487741 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06487741 currently recruiting?
Yes, NCT06487741 is actively recruiting participants. Contact the research team at mps@ucn.dk for enrollment information.
Where is the NCT06487741 trial being conducted?
This trial is being conducted at Aalborg, Denmark.
Who is sponsoring the NCT06487741 clinical trial?
NCT06487741 is sponsored by University College of Northern Denmark. The principal investigator is Lise Eckardt, Pt. Msc at Department of Physiotherapy, University College of Northern Denmark. The trial plans to enroll 58 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.